The governor of Indiana has signed a bill that includes provisions to fund clinical research trials on the therapeutic benefits of psilocybin.
Gov. Eric Holcomb (R) approved the legislation, which broadly focuses on health care issues, but which was amended to add the psychedelics language, last week.
The reform provisions that lawmakers attached to the broader bill were taken from a standalone measure from Sen. Ed Charbonneau (R) that cleared the Senate last month and then advanced through a House committee.
Charbonneau said in a press release that the intent of the proposal is to provide funding to “aid Indiana research institutions in studying the potential use of psilocybin in treating mental health and other medical conditions, especially in veterans and first responders.”
Under the newly signed law, the state will create a therapeutic psilocybin research fund “for the purpose of providing financial assistance to research institutions in Indiana to study…the use of psilocybin to treat mental health and other medical conditions.”
Any research receiving funding under the legislation will need to include veterans and first responders regarding in the study sample.
Researchers will need to apply to the state Department of Health to receive funds to study the substance
Read full article on Marijuana Moment
